Eli Lilly#39;s psoriasis drug has been approved by India#39;s DCGI, allowing the company to enter Indian dermatology market
According to the Indianapolis-based company, Copellor will be a prescription medication that should only be used under medical supervision and upon the recommendation of a dermatologist or rheumatologist.from Moneycontrol Business News https://ift.tt/KHBqAyD
Comments
Post a Comment